Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -784,955 | -589,526 | -526,244 | -388,955 | -215,314 |
| Depreciation Amortization | 10,125 | 9,531 | 11,892 | 5,814 | 2,276 |
| Accounts receivable | -1,114 | -15,367 | -1,136 | 56,672 | -47,399 |
| Accounts payable and accrued liabilities | 2,663 | -4,483 | -3,483 | 4,524 | 1,055 |
| Other Working Capital | -35,628 | 35,664 | 3,089 | -24,704 | 8,456 |
| Other Operating Activity | 298,900 | 168,291 | 101,549 | 47,133 | 108,404 |
| Operating Cash Flow | $-510,009 | $-395,890 | $-414,333 | $-299,516 | $-142,522 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24,807 | -3,906 | -1,416 | -11,335 | -48,872 |
| Purchase Of Investment | -1,068,173 | -1,293,416 | -635,211 | -855,393 | -525,042 |
| Sale Of Investment | 1,109,646 | 744,225 | 875,880 | 604,594 | 426,137 |
| Investing Cash Flow | $16,666 | $-553,097 | $239,253 | $-262,134 | $-147,777 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 729,460 | N/A | N/A | 523,586 | N/A |
| Debt Repayment | -413,513 | -9,618 | -858 | -188,925 | N/A |
| Common Stock Issued | N/A | 656,844 | 164,233 | N/A | 309,285 |
| Other Financing Activity | 208,511 | 283,385 | 57,942 | 181,505 | 10,695 |
| Financing Cash Flow | $524,458 | $930,611 | $221,317 | $516,166 | $319,980 |
| Exchange Rate Effect | -715 | 209 | -20 | N/A | N/A |
| Beginning Cash Position | 95,232 | 113,399 | 67,182 | 112,666 | 82,985 |
| End Cash Position | 125,632 | 95,232 | 113,399 | 67,182 | 112,666 |
| Net Cash Flow | $30,400 | $-18,167 | $46,217 | $-45,484 | $29,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -510,009 | -395,890 | -414,333 | -299,516 | -142,522 |
| Capital Expenditure | -24,807 | -3,906 | -1,416 | -11,335 | -48,872 |
| Free Cash Flow | -534,816 | -399,796 | -415,749 | -310,851 | -191,394 |